Home
About Us
- Team
- Careers
Product & Technology
Investors
News & Events
- Press
Contact

Blog

Discover the latest News of Therapixel

Nothing found.

Search

RECENT POST

Therapixel announces launch of prospective study on the utility of Artificial Intelligence (AI) as part of second reading breast cancer screening mammograms October 19, 2022
Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy May 14, 2022
Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D May 12, 2022
Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis November 28, 2021
Therapixel will be showcasing MammoScreen™ at the virtual ECR 2021 February 25, 2021

TAG CLOUD

AI competition Artificial Intelligence Awareness Breast Cancer Certification cybersecurity Data security DREAM Digital Mammography Challenge ECR European Congress of Radiology FDA Clearance Financing Investment Investor ISO27001 JFR JFR2019 JFR2020 Journées de la SFSPM Journées Francophones de Radiologie MammoScreen Marathon Odyssea Paris Partnership Pink October Presentation Presse release Press release Rad Aid Radiology Reader study RSNA RSNA Annual Meeting SFSPM study Team Website

CATEGORIES

Congress
News
Radiology
Breast cancer
Presse release
Scientific Publications
Press release
Partnership

Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.

Menu

About us
Team
Careers
Product & Technology
Investors
News & Events
Contact

Extras

Legal info
Privacy Policy
Sitemap

Contact

contact @ therapixel.com
+33 (0)9 72 55 20 39

455 Promenade des Anglais

06200 – Nice

© 2023 Therapixel | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences